https://www.selleckchem.com/pr....oducts/pf-03084014-p
To perform an updated review of the literature on the neurological manifestations of COVID-19-infected patients METHODS A PRISMA-guideline-based systematic review was conducted on PubMed, EMBASE, and SCOPUS. Series reporting neurological manifestations of COVID-19 patients were studied. 39 studies and 68,361 laboratory-confirmed COVID-19 patients were included. Up to 21.3% of COVID-19 patients presented neurological symptoms. Headache (5.4%), skeletal muscle injury (5.1%), psychiatric disorders (4.6%), impaired consciousn
Like
Comment
Share
